Congress of the European Society of
Clinical Microbiology and Infectious Diseases
Co-hosted by ESCMID and the Global Leaders Group on Antimicrobial Resistance (GLG) CARB-X, LifeArc and the Gates Foundation.
ESCMID invites you to participate in this joint high-level AMR event co-hosted by ESCMID and the Global Leaders Group on Antimicrobial Resistance (GLG) CARB-X, LifeArc and the Gates Foundation taking place on Friday, 17 April 2026 onsite at ESCMID Global 2026 in Munich, Germany. With the Independent Panel for Evidence for Action against AMR (IPEA) in the making, it is important to move now from commitments into action. Connecting science and policy has never been more important and this meeting aims to bridge that gap.
Two parallel Working Groups will lead into the plenary session. Both are open to all ESCMID Global participants and designed to foster interactive, solution-oriented discussions.
1. Evidence for Policy: Modelling and Economics
This Working Group will examine how modelling and economic analysis can guide effective AMR policy decisions within a One Health context.
The session will be highly interactive and structured around six short interventions by invited discussants, followed by open discussion with all participants.
2. Innovation for Action: Diagnostics and Cost-Effectiveness Across the Product Development and Implementation Pathway
Diagnostics are central to effective AMR mitigation, enabling early detection, targeted treatment, and rational antibiotic use. However, challenges persist across development, evaluation, reimbursement, and implementation - particularly regarding real-world cost-effectiveness, system-level integration, and equitable access.
This Working Group will identify key diagnostic needs, map barriers along the product development and implementation pathway, and propose an evidence-based framework to guide innovation.
The discussion will highlight economic, clinical, and contextual considerations across diverse healthcare settings.
Following a brief introduction, the session will feature six short interventions by invited discussants, followed by an open discussion.
The plenary session will explore the overarching theme AMR Under Pressure: Smart Policies for Lean Times from different perspectives.
Keynote lecture
How AMR policy action can be strengthened under financial and operational constraints—emphasising opportunities to achieve more with limited resources.
This will be followed by four thematic talks covering:
Conclusion
A panel discussion will focus on prioritising cost-effective interventions, aligning national policies with global commitments, and exploring mechanisms for cross-sectoral funding.
Registration for ESCMID Global 2026 in Munich is now open.
Register now to get the early registration fee and attend the world’s most eminent event in the field of infection.